Biotech Showcase At Jpm 2025. News & Events Biocytogen Sörensen, CEO, will together with Rahul Agrawal, Chief Medical Officer and Head of R&D and Jeppe Øvlesen, Board Member, participate at the well-attended investor and networking event Biotech Showcase 2025 Additionally, this pass also grants you access to digital one-to-one.
Jpm Biotech Conference 2025 Judi Lurlene from gennyyestrella.pages.dev
Biotech Showcase 2025 brought together a dynamic community of innovators, investors, and industry leaders for an unforgettable event Biotech Showcase is a premier investor conference that takes place during the busiest week in life sciences
Jpm Biotech Conference 2025 Judi Lurlene
Mendelson oversees a business unit at JPMorgan Chase focused on accelerating the delivery of new care models that improve the quality, equity and affordability of employer-sponsored healthcare. Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to investors and pharmaceutical executives. Dan Mendelson is the Chief Executive Officer of Morgan Health at JPMorgan Chase & Co
We were delighted to have been a presenting company at the BIOTECH Showcase 2023 in San. Mendelson oversees a business unit at JPMorgan Chase focused on accelerating the delivery of new care models that improve the quality, equity and affordability of employer-sponsored healthcare. Our approach combines cutting-edge science and modeling with extensive experience to provide you with a clear, strategic roadmap.
health care conference brings 8,000 to S.F. for first time in three years. Biotech Showcase is a premier investor conference that takes place during the busiest week in life sciences With over 3,000 attendees, including 1,026 investors and 340 presenting companies , the event buzzed with energy, featuring thought-provoking panel discussions and over 6,740 one-to-one meetings that sparked.